Back to results
US 2002/0172676 A1Published application
Method of treatment of alzheimer's disease and device therefor
OwnerGeorge Jackowski, Shirley Fureszinventors
Life of this patent
Estimating the term…
Abstract
A method and device for treating Alzheimer's disease (AD) is disclosed. The method involves the removal of circulating autoantibodies of a biochemical marker or markers, specifically human glial fibrillary acidic protein (GFAP) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in bodily fluid, preferably blood or a blood product. The invention further includes a device or process of immune system modulation effective for autoantibody removal.
Claims4
A process for mitigating the progression of Alzheimer's dementia (AD) comprising:
- determining the presence in circulating body fluid of at least one biochemical marker indicated in the progression of AD;
- and
- removing an amount of said at least one marker effective to mitigate said disease.
A device for mitigating the progression of Alzheimer's dementia (AD) comprising:
- means for removal of at least one marker from circulating body fluid
- whereby said removal includes capture of protein specific antibodies.
Dependencies are inferred from the claim text.